|
Q2 2023
|
134 |
1,973,598 |
13F-HR |
8/14/2023 |
000142050623001706 |
Invenomic Capital Management LP |
|
Q1 2023
|
140 |
1,770,419 |
13F-HR |
5/15/2023 |
000142050623001090 |
Invenomic Capital Management LP |
|
Q4 2022
|
140 |
1,473,429 |
13F-HR |
2/14/2023 |
000142050623000600 |
Invenomic Capital Management LP |
|
Q3 2022
|
146 |
1,164,095 |
13F-HR |
11/14/2022 |
000142050622002300 |
Invenomic Capital Management LP |
|
Q2 2022
|
147 |
1,410,354 |
13F-HR |
8/15/2022 |
000142050622001713 |
Invenomic Capital Management LP |
|
Q1 2022
|
154 |
936,569 |
13F-HR |
5/16/2022 |
000142050622001031 |
Invenomic Capital Management LP |
|
Q4 2021
|
142 |
467,855 |
13F-HR |
2/11/2022 |
000142050622000313 |
Invenomic Capital Management LP |
|
Q3 2021
|
119 |
308,133 |
13F-HR |
11/15/2021 |
000142050621001728 |
Invenomic Capital Management LP |
|
Q2 2021
|
124 |
417,562 |
13F-HR |
8/16/2021 |
000142050621001258 |
Invenomic Capital Management LP |
|
Q1 2021
|
120 |
448,402 |
13F-HR |
5/13/2021 |
000142050621000582 |
Invenomic Capital Management LP |
|
Q4 2020
|
142 |
392,312 |
13F-HR |
2/17/2021 |
000142050621000337 |
Invenomic Capital Management LP |
|
Q3 2020
|
141 |
181,527 |
13F-HR |
11/13/2020 |
000142050620001241 |
Invenomic Capital Management LP |
|
Q2 2020
|
152 |
135,089 |
13F-HR |
8/13/2020 |
000158064220003005 |
Invenomic Capital Management LP |
|
Q1 2020
|
152 |
122,316 |
13F-HR |
5/13/2020 |
000158064220002143 |
Invenomic Capital Management LP |
|
Q4 2019
|
125 |
249,083 |
13F-HR |
2/14/2020 |
000158064220000685 |
Invenomic Capital Management LP |